Hollister Biosciences Logo White

Hollister Biosciences

CSE: HOLL | OTC: HSTRF | FWB: HOB

Canadian cannabis firmĀ Hollister BiosciencesĀ entered into aĀ definitive agreement to acquireĀ AlphamindĀ Brands, andĀ closed the acquisitionĀ in April 2020.Ā AlphamindĀ are conducting R&D into psilocybin-based drug therapies, seeking to build an IP portfolio in the psychedelic medicine space.Ā 

[mstock id="3020"]
[mstock id="3021"]

Latest News

Hollister Biosciences Inc. Provides Update on Q3 2020 Performance

October 27, 2020

Hollister Biosciences 100% Owned Subsidiary Venom Extracts Achieves Initial $30 Million Revenue Milestone

October 6, 2020

Hollister Biosciences Retains Renmark Financial Communications Inc.

September 11, 2020

Hollister Biosciences Inc. Reports Second Quarter 2020 Results

August 24, 2020

Hollister Biosciences Inc. Closes $1.5 Million Private Placement Financing

August 11, 2020

Hollister Biosciences Inc. Announces Private Placement Financing of Up to $1.5 Million

July 2, 2020

Join our Newsletter

Get the latest Company updates delivered to straight to your inbox.